Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04726241 · ClinicalTrials.gov registry record · Phase 1

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

A Phase 1 study of Acute Myeloid Leukemia and Myelodysplastic Syndrome, sponsored by PedAL BCU.

Recruiting
Registry status
Phase 1
Development phase
960
Enrollment target
20
Study locations

NCT04726241 is a Phase 1 study of Acute Myeloid Leukemia and Myelodysplastic Syndrome that is actively recruiting participants, run by PedAL BCU. The registered enrollment target is 960 participants, above the 113-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (750% higher). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04726241, a Phase 1 study of Acute Myeloid Leukemia and Myelodysplastic Syndrome, is actively recruiting participants, sponsored by PedAL BCU.

RECRUITING
Registry status
Phase 1
Development phase
960 participants
Enrollment target
20
Study locations

Study Summary

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide information about the patient's leukemia that is important when deciding how to best treat it, and may help doctors find better ways to diagnose and treat leukemia in children, adolescents, and young adults.

Conditions Studied

Acute Myeloid Leukemia Myelodysplastic Syndrome Acute Lymphoblastic Leukemia Mixed Phenotype Acute Leukemia Juvenile Myelomonocytic Leukemia Acute Myeloid Leukemia Post Cytotoxic Therapy Myeloid Leukemia Associated With Down Syndrome Myelodysplastic Syndrome Post Cytotoxic Therapy

Interventions

  • PROCEDURE Biospecimen Collection

Study Locations (20)

California

  • Kaiser Permanente Downey Medical Center - Downey
  • Loma Linda University Medical Center - Loma Linda
  • Miller Children's and Women's Hospital Long Beach - Long Beach
  • Children's Hospital Los Angeles - Los Angeles
  • Valley Children's Hospital - Madera
  • UCSF Benioff Children's Hospital Oakland - Oakland
  • Kaiser Permanente-Oakland - Oakland
  • Children's Hospital of Orange County - Orange
  • Lucile Packard Children's Hospital Stanford University - Palo Alto
  • Rady Children's Hospital - San Diego - San Diego
  • UCSF Medical Center-Mission Bay - San Francisco

Arizona

  • Banner Children's at Desert - Mesa
  • Phoenix Childrens Hospital - Phoenix
  • Banner University Medical Center - Tucson - Tucson

Alabama

  • Children's Hospital of Alabama - Birmingham
  • USA Health Strada Patient Care Center - Mobile

Colorado

  • Children's Hospital Colorado - Aurora
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center - Denver

Alaska

  • Providence Alaska Medical Center - Anchorage

Arkansas

  • Arkansas Children's Hospital - Little Rock

Trial Details

FieldValue
Enrollment Target 960 participants
Start Date 2022-04-18
Est. Completion 2030-12-31
Phase Phase 1

Sponsor

PedAL BCU

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04726241

The ClinicalTrials.gov registry entry for NCT04726241 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 306 other Acute Myeloid Leukemia trials with a reported enrollment target (750% higher). The listed sponsor is PedAL BCU, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Acute Myeloid Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.

NCT04726241 reports 20 study locations spanning 6 distinct geographic areas - top geographies include California, Arizona, Alabama.

Frequently Asked Questions

What is clinical trial NCT04726241 about?

NCT04726241 is a clinical study titled "The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study". This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treat may provide informati...

What is the current status of trial NCT04726241?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 960 participants. The study started on 2022-04-18. Estimated completion is 2030-12-31.

What conditions does trial NCT04726241 study?

This clinical trial studies the following conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, Juvenile Myelomonocytic Leukemia.

What interventions are being tested in trial NCT04726241?

The interventions under investigation include: Biospecimen Collection (PROCEDURE).

Who is sponsoring clinical trial NCT04726241?

This trial is sponsored by PedAL BCU, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04726241 being conducted?

This trial has 20 study locations across Alabama, Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Myeloid Leukemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Myeloid Leukemia

All registered trials for this condition

Myelodysplastic Syndrome

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.